Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma

NCT00027911 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped Departure of PI

Conditions

Sarcoma

Interventions

BIOLOGICAL: NY-ESO-1 peptide vaccine
BIOLOGICAL: sargramostim

Sponsor

Columbia University

Collaborators

[object Object]